Increase in neutralizing antibody titer against sequential autologous HIV‐1 isolates after 16 weeks saquinavir (invirase) treatment

@article{Sarmati1997IncreaseIN,
  title={Increase in neutralizing antibody titer against sequential autologous HIV‐1 isolates after 16 weeks saquinavir (invirase) treatment},
  author={L. Sarmati and E. Nicastri and G. el-Sawaf and L. Ventura and A. Salanitro and L. Ercoli and S. Vella and M. Andreoni},
  journal={Journal of Medical Virology},
  year={1997},
  volume={53}
}
  • L. Sarmati, E. Nicastri, +5 authors M. Andreoni
  • Published 1997
  • Biology, Medicine
  • Journal of Medical Virology
    • The humoral immune response to HIV infection plays an important role in determining disease progression. Few and discordant results correlate changes in neutralizing antibody (NtAb) titer with antiretroviral treatment. The NtAb titer against autologous‐HIV was evaluated in 33 patients treated with the protease inhibitor saquinavir (SQV, Invirase) and zidovudine (ZDV) alone or in combination. Ten out of 33 (30%) patients showed a significant increase (4‐fold or greater) in NtAb titer from… CONTINUE READING
    View on Wiley
    ncbi.nlm.nih.gov
    18 Citations
    Highly Influential Citations
    1
    Background Citations
    5
    Methods Citations
    3
    Results Citations
    2
    18 Citations
    Citation Type

    Citation Type

    Characterization of the HIV‐1 Specific Humoral Immune Response During Highly Active Antiretroviral Therapy (HAART)
    • 23
    Neutralizing Antibodies against Autologous Human Immunodeficiency Virus Type 1 Isolates in Patients with Increasing CD4 Cell Counts despite Incomplete Virus Suppression during Antiretroviral Treatment
    • 7
    • PDF
    Antiretroviral therapy does not induce HIV type 1-specific neutralizing activity against autologous HIV type 1 isolates.
    • 4
    Selective increases in HIV-specific neutralizing antibody and partial reconstitution of cellular immune responses during prolonged, successful drug therapy of HIV infection.
    • 22
    High Prevalence of M184 Mutation among Patients with Viroimmunologic Discordant Responses to Highly Active Antiretroviral Therapy and Outcomes after Change of Therapy Guided by Genotypic Analysis
    • 16
    • PDF
    Highly Efficient Neutralization by Plasma Antibodies from Human Immunodeficiency Virus Type-1 Infected Individuals on Antiretroviral Drug Therapy
    • 4
    The effect of highly active antiretroviral therapy on binding and neutralizing antibody responses to human immunodeficiency virus type 1 infection.
    • 74
    • PDF
    Neutralization potential of the plasma of HIV-1 infected Indian patients in the context of anti-V3 antibody content and antiretroviral theraphy
    • 9
    Human immunodeficiency virus‐1 specific and natural cellular immunity in HIV seronegative subjects with multiple sexual exposures to virus
    • 11
    Adherence and Genotypic Drug Resistance Mutations in HIV-1-Infected Patients Failing Current Antiretroviral Therapy
    • 3

    References

    SHOWING 1-10 OF 20 REFERENCES
    Human immunodeficiency virus (HIV) type 1 strain MN neutralizing antibody in HIV-infected children: correlation with clinical status and prognostic value.
    • 23
    Isolate-specific neutralizing antibodies in patients with progressive HIV-1-related disease.
    • 66
    Neutralizing and infection-enhancing antibody responses to human immunodeficiency virus type 1 in long-term nonprogressors.
    • 273
    • PDF
    A randomized controlled trial of a protease inhibitor (saquinavir) in combination with zidovudine in previously untreated patients with advanced HIV infection.
    • 18
    Neutralizing antibodies against sequential autologous human immunodeficiency virus type 1 isolates after seroconversion.
    • 41
    Virus neutralizing antibodies at different stages of the HIV disease: increased levels after azidothymidine treatment.
    • 4
    Rapid development of isolate-specific neutralizing antibodies after primary HIV-1 infection and consequent emergence of virus variants which resist neutralization by autologous sera.
    • 405
    Enhanced Fidelity of 3TC-Selected Mutant HIV-1 Reverse Transcriptase
    • 285
    Homotypic antibody responses to fresh clinical isolates of human immunodeficiency virus.
    • 64
    Spectrum of HIV-1 neutralizing antibodies in a cohort of homosexual men: results of a 6 year prospective study.
    • 43